Effects of indomethacin and iloprost on contraction of the afferent arterioles by endothelin-1 in juxtamedullary nephron preparations from normotensive Wistar-Kyoto and spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 6, 1996, Pages 809-816

  Rita Gonzalez, M ^a   Villa, Eduardo ^b   García Robles, Rafael ^b   Angulo, Javier ^a   Peiró, Concepción ^a   Marín, Jesús ^a   Sánchez Ferrer, Carlos F ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Afferent arterioles; Endothelin 1; Hypertension; Prostanoids

Indexed keywords

ENDOTHELIN 1; ILOPROST; INDOMETACIN; NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME INHIBITION; KIDNEY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ANIMALS; ARTERIOLES; CYCLOOXYGENASE INHIBITORS; ENDOTHELIN-1; ILOPROST; INDOMETHACIN; MALE; NEPHRONS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 10544223265     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199612000-00011     Document Type: Article

References (62)

1. Tomobe Y, Miyauchi T, Saito A, et al. Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar-Kyoto rats. Eur J Pharmacol 1988;152:373-4.
2. Hirata Y, Matsuoka H, Kimura K, et al. Renal vasoconstriction by the endothelial cell-derived peptide endothelin in spontaneously hypertensive rats. Circ Res 1989;65:1370-9.
3. López-Farré A, Montañés I, Millás I, López-Novoa JM. Effect of endothelin on renal function in rats. Eur J Pharmacol 1989;163: 187-9.
4. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989;256:F1051-8.
5. Badr KF, Murray JJ, Breyer MD, Takahashi K., Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. J Clin Invest 1989;83:336-42.
6. Cairns HS, Rogerson ME, Fairbanks LD, Neild GH, Westwick J. Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney. Br J Phamacol 1989;9:155-60.
7. 2 in anesthetized dogs. Eur J Pharmacol 1989;170:91-3.
8. Banks RO. Effects of endothelin on renal function in dogs and rats. Am J Physiol 1990;258:F775-80.
9. Stacy DL, Scott JW, Granger JR Control of renal function during intrarenal infusion of endothelin. Am J Physiol 1990;258:F1232-6.
10. Munger CA, Takahashi K, Awazu M, Frazer M, Falk SA, Conger JD, Badr KF. Maintenance of endothelin-induced renal arteriolar constriction in rats is cyclooxygenase dependent. Am J Physiol 1993;264:F637-44.
11. Loutzenhiser R, Epstein M, Hayashi K, Horton C. Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol 1990;258:F61-8.
12. Fretschner M, Endlich K, Gulbins E, Lang RE, Scholottman K, Steinhausen M. Effects of endothelin on the renal microcirculation of the split hydronephrotic rat kidney. Renal Physiol Biochem 1991;14:112-27.
13. Edwards RM, Trizna W, Ohlstein EH. Renal microvascular effects of endothelin. Am J Physiol 1990;259:F17-21.
14. Madeddu P, Troffa C, Glorioso N, et al. Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats. J Cardiovasc Pharmacol 1989;14:818-25.
15. King AJ, Brenner BM. Endothelium-derived vasoactive factors and the renal vasculature. Am J Physiol 1991;260:R653-62.
16. Levin ER. Endothelins. N Engl J Med 1995;333:356-61.
17. A receptors in the rabbit kidney. Eur J Pharmacol 1993;237:275-81.
18. Maguire JJ, Kuc RE, O'Reilly G, Davenport AP. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol 1994;113:49-54.
19. A receptors in human kidney which localizes to renal vasculature. Br J Pharmacol 1994;113:1303-10.
20. B receptors mediate vasoconstriction and prostanoids release in the isolated kidney of the rat. Eur J Pharmacol 1993;250:447-53.
21. Cristol JP, Warner TD, Thiemermann C, Vane JR. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol 1993;108:776-9.
22. B receptor-mediated vasconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol 1994;111:515-20.
23. B receptors mediate contraction to endothelin-1 in renal artery of aging SHR: effects of FR139317 and bosentan. Hypertension 1995;25:501-6.
24. Clavell AL, Stingo AJ, Margulies KB, Brandt RR, Burnett JC. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol 1995;268:F455-60.
25. Chou SY, Dahhan A, Porush JG. Renal actions of endothelin: interaction with prostacyclin. Am J Physiol 1990;59:F645-52.
26. Chou SY, Porush JG. Renal actions of endothelin-1 and endothelin- 3: interactions with the prostaglandin system and nitric oxide. Am J Kidney Dis 1995;26:116-23.
27. Perico N, Dadan J, Gabanelli M, Remuzzi G. Cyclooxygenase products and atrial natriuretic peptide modulate renal, response to endothelin. J Pharmacol Exp Ther 1989;252:1213-20.
28. Evangelista S, Maggi CA, Castellucci A. Effects of endothelin (ET)-1, ET-3 and ET-(16-21) on the isolated and perfused rat kidney from normotensive and spontaneously hypertensive rats. Jpn J Pharmacol 1992;59:239-41.
29. Roberts-Thomsom P, McRitchie RJ, Chalmen JP. Experimental hypertension produces diverse changes in the regional vascular responses to endothelin-1 in the rabbit and the rat. J Hypertens 1994;12:1225-34.
30. Bolger GT, Liard P, Jodoin A, Jaramillo J. Vascular reactivity, tissue levels, and binding sites for endothelin: a comparison in the spontaneously hypertensive and Wistar-Kyoto rats. Can J Physiol Pharmacol 1991;69:406-13.
31. Hughes AK, Cline RC, Kohan DE. Alterations in renal ensothelin-1 production in the spontaneously hypertensive rat. Hypertension 1992;20:666-73.
32. Kato T, Kassab S, Wilkins FC Jr, Kirchner KA, Keiser J, Granger JP. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension 1995;25:883-7.
33. Quilley J, McGiff JC. Renal vascular responsiveness to arachidonic acid in experimental diabetes. Br J Pharmacol 1990;100:336-40.
34. DeRubertis FR, Craven PA. Eicosanoids in the pathogenesis of the functional and structural alterations in the kidney in diabetes. Am J Kidney Dis 1993;22:727-35.
35. Bank N, Aynedjian HS. Role of thromboxane in impaired renal vasodilatation response to acetylcholine in hypercholesterolemic rats. J Clin Invest 1992;89:1636-42.
36. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Bühler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension 1988;11:573-8.
37. Chatziantoniou C, Daniels FH, Arendhorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol 1990;259:F372-82.
38. Takemoto F, Miyanoshita A, Shimamura K, Sunano S, Endou H. Intranephron PGE2 production in stroke-prone spontaneously hypertensive rats. Am J Physiol 1990;258:H987-93.
39. 2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension 1992;19:795-8.
40. Chatziantoniou C, Arendhorst WJ. Renal vascular reactivity to vasodilator prostaglandins in genetically hypertensive rats. Am J Physiol 1992;262:F124-30.
41. Chatziantoniou C, Arendhorst WJ. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am J Physiol 1992;263:F573-80.
42. Chatziantoniou C, Arendhorst WJ. Vascular interactions of prostaglandins with thromboxane in kidneys of rats developing hypertension. Am J Physiol 1993;265:F250-6.
43. Casellas D, Navar LG. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol 1984;246:F349-58.
44. Sánchez-Ferrer CF, Roman RJ, Harder DR. Pressure-dependent contraction of rat juxtamedullary afferent arterioles. Circ Res 1989;64:790-8.
45. González R, Fernández-Alfonso MS, Rodríguez-Martínez MA, et al. Pressure-induced contraction of the juxtamedullary afferent arterioles in spontaneously hypertensive rats. Gen Pharmacol 1994; 25:333-9.
46. Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced vascular tone in the renal vascularure of spontaneously hypertensive rats. Hypertension 1990;16:648-54.
47. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res 1989;65:1475-84.
48. Ito S, Juncos LA, Carretero OA. Pressure-induced constriction of the afferent arteriole of spontaneously hypertensive rats. Hypertension 1992;19(suppl II):II164-7.
49. Cao L, Banks RO. Cardiovascular and renal actions of endothelin: effects of calcium-channel blockers. Am J Physiol 1990;258: F254-8.
50. Katoh T, Chang H, Uchida S, Okuda T, Kurokawa K. Direct effects of endothelin in the rat kidney. Am J Physiol 1990;258:F397-402.
51. Kaasjager KA, van Rijn HJM, Koomans HA, Rabelink TJ. Interactions of nifedipine with the renovascular effects of endothelin in humans. J Pharmacol Exp Ther 1995;275:306-11.
52. Loutzenhiser R, Epstein M, Horton C, Sonke P. Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction. J Pharmacol Exp Ther 1985;232:3827.
53. Fleming JT, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol 1987;253:F1157-63.
54. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol 1989;256:F1015-20.
55. Roman RJ. Alterations in renal medullary hemodynamics and the pressure natriuretic responses in genetic hypertension. Am J Hypertens 1990;3:893-900.
56. Hayashi K, Epstein M, Loutzenhiser R. Enhanced myogenic responsiveness of renal interlobular arteries in spontaneously hypertensive rats. Hypertension 1992;19:153-60.
57. A-dependent pressor effects and release of prostacyclin induced by endothelins in pulmonary and renal vasculature. J Cardiovasc Pharmacol 1993; 22(suppl 8):S235-8.
58. Stier CT, Quilley CP, McGiff JC. Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney. J Pharmacol Exp Ther 1992;262:252-6.
59. Tuncer M, Vanhoutte PM. Role of prostanoids in the increased vascular responsiveness and delayed tachyphylaxis to serotonin in the kidney of spontaneously hypertensive rats. J Hypertens 1991;9: 623-9.
60. Haberey M, Loge O, Maab B, Ohme G. Hemodynamic profile of iloprost in rats, rabbits, and cats. In: Glyglewski RJ, Stock G, eds. Prostacyclin and its stable analogue iloprost. Berlin, Germany: Springer-Verlag, 1985:151-8.
61. Villa E, Morales ME, Martinez J, et al. Acute effects of iloprost on blood pressure, heart rate, renal memodynamics, diuresis, natriuresis, plasma renin activity and plasma norepinephrine in uninephrectomized hypertensive mongrel dogs. J Hypertens 1991;9(suppl 6): S352-3.
62. Chatziantoniou C, Arendhorst WJ. Prostaglandin interactions with angiotensin, norpinephrine, and thromboxane in rat renal vasculature. Am J Physiol 1992;262:F68-76.